Article Details

Lilly signs an Additional Voluntary Licensing Agreement on Baricitinib

Retrieved on: 2021-05-17 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

Lilly signs an Additional Voluntary Licensing Agreement on Baricitinib. View article details on hiswai:

Excerpt

... combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19 in hospitalized adults requiring supplemental oxygen, ...

Article found on: www.sify.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up